These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17451426)

  • 1. Beta cells in type 2 diabetes - a crucial contribution to pathogenesis.
    Maedler K
    Diabetes Obes Metab; 2008 May; 10(5):408-20. PubMed ID: 17451426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequences.
    Lupi R; Del Prato S
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S56-64. PubMed ID: 18640587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional pancreatic beta-cell mass: involvement in type 2 diabetes and therapeutic intervention.
    Karaca M; Magnan C; Kargar C
    Diabetes Metab; 2009 Apr; 35(2):77-84. PubMed ID: 19251449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes.
    Donath MY; Böni-Schnetzler M; Ellingsgaard H; Ehses JA
    Physiology (Bethesda); 2009 Dec; 24():325-31. PubMed ID: 19996363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anatomical versus functional beta-cell mass in experimental diabetes.
    Kargar C; Ktorza A
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():43-53. PubMed ID: 18834432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of beta-cell management in type 2 diabetes.
    Standl E
    Int J Clin Pract Suppl; 2007 Jun; (153):10-9. PubMed ID: 17594389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of insulin sensitivity, -cell function, and -cell mass during the development of diabetes in fa/fa rats.
    Topp BG; Atkinson LL; Finegood DT
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1730-5. PubMed ID: 17895283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of beta-cell dysfunction, ectopic fat accumulation and insulin resistance in the pathogenesis of type 2 diabetes mellitus.
    Gastaldelli A
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S60-5. PubMed ID: 21864753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of the intravenous and oral glucose tolerance tests for detecting subtle impairments in insulin sensitivity and beta-cell function in former gestational diabetes.
    Tura A; Mari A; Prikoszovich T; Pacini G; Kautzky-Willer A
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):237-43. PubMed ID: 18194489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDL and LDL cholesterol significantly influence beta-cell function in type 2 diabetes mellitus.
    Kruit JK; Brunham LR; Verchere CB; Hayden MR
    Curr Opin Lipidol; 2010 Jun; 21(3):178-85. PubMed ID: 20463468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crucial role of insulin receptor substrate-2 in compensatory beta-cell hyperplasia in response to high fat diet-induced insulin resistance.
    Takamoto I; Terauchi Y; Kubota N; Ohsugi M; Ueki K; Kadowaki T
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():147-56. PubMed ID: 18834442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis in the pathophysiology of diabetes mellitus.
    Lee SC; Pervaiz S
    Int J Biochem Cell Biol; 2007; 39(3):497-504. PubMed ID: 17074529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct in vivo roles of caspase-8 in beta-cells in physiological and diabetes models.
    Liadis N; Salmena L; Kwan E; Tajmir P; Schroer SA; Radziszewska A; Li X; Sheu L; Eweida M; Xu S; Gaisano HY; Hakem R; Woo M
    Diabetes; 2007 Sep; 56(9):2302-11. PubMed ID: 17563067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiazolidinediones and the preservation of beta-cell function, cellular proliferation and apoptosis.
    Decker M; Hofflich H; Elias AN
    Diabetes Obes Metab; 2008 Aug; 10(8):617-25. PubMed ID: 17645549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone prevents diabetes by increasing beta-cell mass in an animal model of type 2 diabetes characterized by reduced beta-cell mass at birth.
    Holloway AC; Petrik JJ; Bruin JE; Gerstein HC
    Diabetes Obes Metab; 2008 Sep; 10(9):763-71. PubMed ID: 17970760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic beta-cell hyperactivity in morbidly obese adolescents.
    Mercado AB; Castells S
    Pediatr Endocrinol Rev; 2006 Dec; 3 Suppl 4():560-3. PubMed ID: 17237743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma proteome changes in subjects with Type 2 diabetes mellitus with a low or high early insulin response.
    Sundsten T; Zethelius B; Berne C; Bergsten P
    Clin Sci (Lond); 2008 Apr; 114(7):499-507. PubMed ID: 17961122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.